Scientists have found a way to transform hard-to-treat tumors into targets for the immune system. Using two protein stimulators, they activated strong T-cell and B-cell responses and built immune structures inside tumors that improved survival and prevented recurrence. This approach could make existing immunotherapies and chemotherapies more effective and long-lasting.
